{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:16:28Z","timestamp":1791807388570,"version":"4.3.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T00:00:00Z","timestamp":1605744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Duchenne muscular dystrophy (DMD) is a progressive, degenerative muscular disorder and cognitive dysfunction caused by mutations in the dystrophin gene. It is characterized by excess inflammatory responses in the muscle and repeated degeneration and regeneration cycles. Neutral sphingomyelinase 2\/sphingomyelin phosphodiesterase 3 (nSMase2\/Smpd3) hydrolyzes sphingomyelin in lipid rafts. This protein thus modulates inflammatory responses, cell survival or apoptosis pathways, and the secretion of extracellular vesicles in a Ca<jats:sup>2+<\/jats:sup>-dependent manner. However, its roles in dystrophic pathology have not yet been clarified.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>To investigate the effects of the loss of nSMase2\/Smpd3 on dystrophic muscles and its role in the abnormal behavior observed in DMD patients, we generated <jats:italic>mdx<\/jats:italic> mice lacking the <jats:italic>nSMase2\/Smpd3<\/jats:italic> gene (<jats:italic>mdx:Smpd3<\/jats:italic> double knockout [DKO] mice).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Young <jats:italic>mdx:Smpd3<\/jats:italic> DKO mice exhibited reduced muscular degeneration and decreased inflammation responses, but later on they showed exacerbated muscular necrosis. In addition, the abnormal stress response displayed by <jats:italic>mdx<\/jats:italic> mice was improved in the <jats:italic>mdx:Smpd3<\/jats:italic> DKO mice, with the recovery of brain-derived neurotrophic factor (Bdnf) expression in the hippocampus.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>nSMase2\/Smpd3-modulated lipid raft integrity is a potential therapeutic target for DMD.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12916-020-01805-5","type":"journal-article","created":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T02:02:55Z","timestamp":1605751375000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["The nSMase2\/Smpd3 gene modulates the severity of muscular dystrophy and the emotional stress response in mdx mice"],"prefix":"10.1186","volume":"18","author":[{"given":"Yasunari","family":"Matsuzaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tanihata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Ooshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Sekiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouta","family":"Miyatake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitsugu","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Terumitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryu","family":"Yashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Komaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Ishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Oya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko U.","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin\u2019ichi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6677-3546","authenticated-orcid":false,"given":"Kazuo","family":"Hashido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,19]]},"reference":[{"key":"1805_CR1","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ccm.2018.01.004","volume":"39","author":"JC Carter","year":"2018","unstructured":"Carter JC, Sheehan DW, Prochoroff A, Birnkrant DJ. Muscular dystrophies. Clin Chest Med. 2018;39:377\u201389. https:\/\/doi.org\/10.1016\/j.ccm.2018.01.004.","journal-title":"Clin Chest Med"},{"key":"1805_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11940-018-0513-6","volume":"20","author":"M Crone","year":"2018","unstructured":"Crone M, Mah JK. Current and emerging therapies for Duchenne muscular dystrophy. Curr Treat Options Neurol. 2018;20:31. https:\/\/doi.org\/10.1007\/s11940-018-0513-6.","journal-title":"Curr Treat Options Neurol"},{"key":"1805_CR3","doi-asserted-by":"publisher","unstructured":"Heydemann A. Skeletal muscle metabolism in Duchenne and Becker muscular dystrophy\u2014implications for therapies. Nutrients. 2018;10. https:\/\/doi.org\/10.3390\/nu10060796.","DOI":"10.3390\/nu10060796"},{"key":"1805_CR4","doi-asserted-by":"publisher","unstructured":"Smith LR, Barton ER. Regulation of fibrosis in muscular dystrophy. Matrix Biol. 2018;68\u20139:602\u201315. doi:https:\/\/doi.org\/10.1016\/j.matbio.2018.01.014.","DOI":"10.1016\/j.matbio.2018.01.014"},{"key":"1805_CR5","doi-asserted-by":"publisher","unstructured":"Thakur SS, Swiderski K, Ryall JG, Lynch GS. Therapeutic potential of heat shock protein induction for muscular dystrophy and other muscle wasting conditions. Philos Trans R Soc Lond B Biol Sci. 2018;373. https:\/\/doi.org\/10.1098\/rstb.2016.0528.","DOI":"10.1098\/rstb.2016.0528"},{"key":"1805_CR6","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/s0092-8674(02)00907-8","volume":"110","author":"RD Cohn","year":"2002","unstructured":"Cohn RD, Henry MD, Michele DE, Barresi R, Saito F, Moore SA, et al. Disruption of DAG1 in differentiated skeletal muscle reveals a role for dystroglycan in muscle regeneration. Cell. 2002;110:639\u201348. https:\/\/doi.org\/10.1016\/s0092-8674(02)00907-8.","journal-title":"Cell."},{"key":"1805_CR7","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/nm.3990","volume":"21","author":"NA Dumont","year":"2015","unstructured":"Dumont NA, Wang YX, von Maltzahn J, Pasut A, Bentzinger CF, Brun CE, et al. Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division. Nat Med. 2015;21:1455\u201363. https:\/\/doi.org\/10.1038\/nm.3990.","journal-title":"Nat Med"},{"key":"1805_CR8","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/nm.4006","volume":"21","author":"AC Keefe","year":"2015","unstructured":"Keefe AC, Kardon G. A new role for dystrophin in muscle stem cells. Nat Med. 2015;21:1391\u20133. https:\/\/doi.org\/10.1038\/nm.4006.","journal-title":"Nat Med"},{"key":"1805_CR9","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.molmed.2016.04.002","volume":"22","author":"NC Chang","year":"2016","unstructured":"Chang NC, Chevalier FP, Rudnicki MA. Satellite cells in muscular dystrophy\u2014lost in polarity. Trends Mol Med. 2016;22:479\u201396. https:\/\/doi.org\/10.1016\/j.molmed.2016.04.002.","journal-title":"Trends Mol Med"},{"key":"1805_CR10","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.stem.2018.10.006","volume":"23","author":"P Feige","year":"2018","unstructured":"Feige P, Brun CE, Ritso M, Rudnicki MA. Orienting muscle stem cells for regeneration in homeostasis, aging, and disease. Cell Stem Cell. 2018;23:653\u201364. https:\/\/doi.org\/10.1016\/j.stem.2018.10.006.","journal-title":"Cell Stem Cell"},{"key":"1805_CR11","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/s41467-018-03425-3","volume":"9","author":"SS Rayagiri","year":"2018","unstructured":"Rayagiri SS, Ranaldi D, Raven A, Azhar NIFM, Lefebvre O, Zammit PS, et al. Basal lamina remodeling at the skeletal muscle stem cell niche mediates stem cell self-renewal. Nat Commun. 2018;9:1075. https:\/\/doi.org\/10.1038\/s41467-018-03425-3.","journal-title":"Nat Commun"},{"key":"1805_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1093\/brain\/awn253","volume":"132","author":"M Sekiguchi","year":"2009","unstructured":"Sekiguchi M, Zushida K, Yoshida M, Maekawa M, Kamichi S, Yoshida M, et al. A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice. Brain. 2009;132:124\u201335. https:\/\/doi.org\/10.1093\/brain\/awn253.","journal-title":"Brain."},{"key":"1805_CR13","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/gbb.12301","volume":"15","author":"E Remmelink","year":"2016","unstructured":"Remmelink E, Aartsma-Rus A, Smit AB, Verhage M, Loos M, van Putten M. Cognitive flexibility deficits in a mouse model for the absence of full-length dystrophin. Genes Brain Behav. 2016;15:558\u201367. https:\/\/doi.org\/10.1111\/gbb.12301.","journal-title":"Genes Brain Behav"},{"key":"1805_CR14","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1093\/hmg\/ddx013","volume":"26","author":"C Vaillend","year":"2017","unstructured":"Vaillend C, Chaussenot R. Relationships linking emotional, motor, cognitive and GABAergic dysfunctions in dystrophin-deficient mdx mice. Hum Mol Genet. 2017;26:1041\u201355. https:\/\/doi.org\/10.1093\/hmg\/ddx013.","journal-title":"Hum Mol Genet"},{"key":"1805_CR15","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/j.bbamem.2018.05.002","volume":"2018","author":"K Raghunathan","year":"1860","unstructured":"Raghunathan K, Kenworthy AK. Dynamic pattern generation in cell membranes: current insights into membrane organization. Biochim Biophys Acta Biomembr. 1860;2018:2018\u201331. https:\/\/doi.org\/10.1016\/j.bbamem.2018.05.002.","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"1805_CR16","doi-asserted-by":"publisher","unstructured":"Sych T, Mely Y, Romer W. Lipid self-assembly and lectin-induced reorganization of the plasma membrane. Philos Trans R Soc Lond B Biol Sci. 2018;373. https:\/\/doi.org\/10.1098\/rstb.2017.0117.","DOI":"10.1098\/rstb.2017.0117"},{"key":"1805_CR17","doi-asserted-by":"publisher","first-page":"L614","DOI":"10.1152\/ajplung.00141.2015","volume":"309","author":"GS Supinski","year":"2015","unstructured":"Supinski GS, Alimov AP, Wang L, Song XH, Callahan LA. Neutral sphingomyelinase 2 is required for cytokine-induced skeletal muscle calpain activation. Am J Physiol Lung Cell Mol Physiol. 2015;309:L614\u201324. https:\/\/doi.org\/10.1152\/ajplung.00141.2015.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"1805_CR18","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.freeradbiomed.2016.02.006","volume":"93","author":"C Camare","year":"2016","unstructured":"Camare C, Auge N, Pucelle M, Saint-Lebes B, Grazide MH, Negre-Salvayre A, et al. The neutral sphingomyelinase-2 is involved in angiogenic signaling triggered by oxidized LDL. Free Radic Biol Med. 2016;93:204\u201316. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.02.006.","journal-title":"Free Radic Biol Med"},{"key":"1805_CR19","doi-asserted-by":"publisher","first-page":"7488","DOI":"10.1074\/jbc.RA118.007288","volume":"294","author":"P Shanbhogue","year":"2019","unstructured":"Shanbhogue P, Hoffmann RM, Airola MV, Maini R, Hamelin DJ, Garcia-Diaz M, et al. The juxtamembrane linker in neutral sphingomyelinase-2 functions as an intramolecular allosteric switch that activates the enzyme. J Biol Chem. 2019;294:7488\u2013502. https:\/\/doi.org\/10.1074\/jbc.RA118.007288.","journal-title":"J Biol Chem"},{"key":"1805_CR20","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1161\/ATVBAHA.118.311208","volume":"38","author":"T Lallemand","year":"2018","unstructured":"Lallemand T, Rouahi M, Swiader A, Grazide MH, Geoffre N, Alayrac P, et al. nSMase2 (type 2-neutral sphingomyelinase) deficiency or inhibition by GW4869 reduces inflammation and atherosclerosis in Apoe\u2212\/\u2212 mice. Arterioscler Thromb Vasc Biol. 2018;38:1479\u201392. https:\/\/doi.org\/10.1161\/ATVBAHA.118.311208.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1805_CR21","doi-asserted-by":"publisher","first-page":"5096","DOI":"10.1073\/pnas.88.12.5096","volume":"88","author":"PS Jat","year":"1991","unstructured":"Jat PS, Noble MD, Ataliotis P, Tanaka Y, Yannoutsos N, Larsen L, et al. Direct derivation of conditionally immortal cell lines from an H-2Kb-tsA58 transgenic mouse. Proc Natl Acad Sci U S A. 1991;88:5096\u2013100. https:\/\/doi.org\/10.1073\/pnas.88.12.5096.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1805_CR22","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.omtn.2019.01.008","volume":"14","author":"S Miyatake","year":"2019","unstructured":"Miyatake S, Mizobe Y, Tsoumpra MK, Lim KRQ, Hara Y, Shabanpoor F, et al. Scavenger receptor class A1 mediates uptake of morpholino antisense oligonucleotide into dystrophic skeletal muscle. Mol Ther Nucleic Acids. 2019;14:520\u201335. https:\/\/doi.org\/10.1016\/j.omtn.2019.01.008.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1805_CR23","doi-asserted-by":"publisher","first-page":"e0167811","DOI":"10.1371\/journal.pone.0167811","volume":"11","author":"Y Matsuzaka","year":"2016","unstructured":"Matsuzaka Y, Tanihata J, Komaki H, Ishiyama A, Oya Y, Ruegg U, et al. Characterization and functional analysis of extracellular vesicles and muscle-abundant miRNAs (miR-1, miR-133a, and miR-206) in C2C12 myocytes and mdx mice. PLoS One. 2016;11:e0167811. https:\/\/doi.org\/10.1371\/journal.pone.0167811.","journal-title":"PLoS One"},{"key":"1805_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/B978-0-12-801185-0.00015-5","volume":"546","author":"Y Fujihara","year":"2014","unstructured":"Fujihara Y, Ikawa M. CRISPR\/Cas9-based genome editing in mice by single plasmid injection. Methods Enzymol. 2014;546:319\u201336. https:\/\/doi.org\/10.1016\/B978-0-12-801185-0.00015-5.","journal-title":"Methods Enzymol"},{"key":"1805_CR25","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/dgd.12113","volume":"56","author":"D Mashiko","year":"2014","unstructured":"Mashiko D, Young SA, Muto M, Kato H, Nozawa K, Ogawa M, et al. Feasibility for a large scale mouse mutagenesis by injecting CRISPR\/Cas plasmid into zygotes. Develop Growth Differ. 2014;56:122\u20139. https:\/\/doi.org\/10.1111\/dgd.12113.","journal-title":"Develop Growth Differ"},{"key":"1805_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bbrc.2018.09.039","volume":"505","author":"J Tanihata","year":"2018","unstructured":"Tanihata J, Nagata T, Ito N, Saito T, Nakamura A, Minamisawa S, et al. Truncated dystrophin ameliorates the dystrophic phenotype of mdx mice by reducing sarcolipin-mediated SERCA inhibition. Biochem Biophys Res Commun. 2018;505:51\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2018.09.039.","journal-title":"Biochem Biophys Res Commun"},{"key":"1805_CR27","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.3389\/fimmu.2019.02131","volume":"10","author":"LH Ouisse","year":"2019","unstructured":"Ouisse LH, Remy S, Lafoux A, Larcher T, Tesson L, Chenouard V, et al. Immunophenotype of a rat model of Duchenne's disease and demonstration of improved muscle strength after anti-CD45RC antibody treatment. Front Immunol. 2019;10:2131. https:\/\/doi.org\/10.3389\/fimmu.2019.02131.","journal-title":"Front Immunol"},{"key":"1805_CR28","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1083\/jcb.200105110","volume":"155","author":"M Wehling","year":"2001","unstructured":"Wehling M, Spencer MJ, Tidball JG. A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice. J Cell Biol. 2001;155:123\u201331. https:\/\/doi.org\/10.1083\/jcb.200105110.","journal-title":"J Cell Biol"},{"key":"1805_CR29","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1111\/j.1471-4159.2009.06038.x","volume":"109","author":"D Wheeler","year":"2009","unstructured":"Wheeler D, Knapp E, Bandaru VV, Wang Y, Knorr D, Poirier C, et al. Tumor necrosis factor-\u03b1-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors. J Neurochem. 2009;109:1237\u201349. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06038.x.","journal-title":"J Neurochem"},{"key":"1805_CR30","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1038\/mt.2010.186","volume":"18","author":"Y Aoki","year":"2010","unstructured":"Aoki Y, Nakamura A, Yokota T, Sait T, Okazawa H, Nagata T, et al. In-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse. Mol Ther. 2010;18:1995\u20132005. https:\/\/doi.org\/10.1038\/mt.2010.186.","journal-title":"Mol Ther"},{"issue":"3","key":"1805_CR31","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1172\/JCI43844","volume":"121","author":"SA Goonasekera","year":"2011","unstructured":"Goonasekera SA, Lam CK, Millay DP, Sargent MA, Hajjar RJ, Kranias EG, et al. Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle. J Clin Invest. 2011;121(3):1044\u201352. https:\/\/doi.org\/10.1172\/JCI43844.","journal-title":"J Clin Invest"},{"key":"1805_CR32","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.ajpath.2016.12.019","volume":"187","author":"J Hyzewicz","year":"2017","unstructured":"Hyzewicz J, Tanihata J, Kuraoka M, Nitahara-Kasahara Y, Beylier T, Ruegg UT, et al. Low-intensity training and the C5a complement antagonist NOX-D21 rescue the mdx phenotype through modulation of inflammation. Am J Pathol. 2017;187:1147\u201361. https:\/\/doi.org\/10.1016\/j.ajpath.2016.12.019.","journal-title":"Am J Pathol"},{"key":"1805_CR33","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.3390\/molecules19021568","volume":"19","author":"Q Ge","year":"2014","unstructured":"Ge Q, Zhou Y, Lu J, Bai Y, Xie X, Lu Z. miRNA in plasma exosome is stable under different storage conditions. Molecules. 2014;19:1568\u201375. https:\/\/doi.org\/10.3390\/molecules19021568.","journal-title":"Molecules."},{"key":"1805_CR34","doi-asserted-by":"publisher","unstructured":"Komaki H, Nagata T, Saito T, Masuda S, Takeshita E, Sasaki M, et al. Systemic administration of the antisense oligonucleotide NS-065\/NCNP-01 for skipping of exon 53 in patients with Duchenne muscular dystrophy. Sci Transl Med. 2018;10. https:\/\/doi.org\/10.1126\/scitranslmed.aan0713.","DOI":"10.1126\/scitranslmed.aan0713"},{"key":"1805_CR35","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1038\/mtna.2012.26","volume":"1","author":"TC Roberts","year":"2012","unstructured":"Roberts TC, Blomberg KE, McClorey G, Andaloussi SEL, Godfrey C, Betts C, et al. Expression analysis in multiple muscle groups and serum reveals complexity in the microRNA transcriptome of the mdx mouse with implications for therapy. Mol Ther Nucleic Acids. 2012;1:e39. https:\/\/doi.org\/10.1038\/mtna.2012.26.","journal-title":"Mol Ther Nucleic Acids."},{"key":"1805_CR36","doi-asserted-by":"publisher","first-page":"9500","DOI":"10.1093\/nar\/gkt724","volume":"41","author":"TC Roberts","year":"2013","unstructured":"Roberts TC, Godfrey C, McClorey G, Vader P, Briggs D, Gardiner C, et al. Extracellular microRNAs are dynamic non-vesicular biomarkers of muscle turnover. Nucleic Acids Res. 2013;41:9500\u201313. https:\/\/doi.org\/10.1093\/nar\/gkt724.","journal-title":"Nucleic Acids Res"},{"key":"1805_CR37","doi-asserted-by":"publisher","first-page":"11247","DOI":"10.1021\/bi061307z","volume":"45","author":"CJ Clarke","year":"2006","unstructured":"Clarke CJ, Snook CF, Tani M, Matmati N, Marchesini N, Hannun YA. The extended family of neutral sphingomyelinases. Biochemistry. 2006;45:11247\u201356. https:\/\/doi.org\/10.1021\/bi061307z.","journal-title":"Biochemistry."},{"key":"1805_CR38","doi-asserted-by":"publisher","first-page":"5741","DOI":"10.1007\/s12035-017-0784-z","volume":"55","author":"LH Tan","year":"2018","unstructured":"Tan LH, Tan AJ, Ng YY, Chua JJ, Chew WS, Muralidharan S, et al. Enriched expression of neutral sphingomyelinase 2 in the striatum is essential for regulation of lipid raft content and motor coordination. Mol Neurobiol. 2018;55:5741\u201356. https:\/\/doi.org\/10.1007\/s12035-017-0784-z.","journal-title":"Mol Neurobiol"},{"key":"1805_CR39","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1093\/hmg\/ddn376","volume":"18","author":"SA Villalta","year":"2009","unstructured":"Villalta SA, Nguyen HX, Deng B, Gotoh T, Tidball JG. Shifts in macrophage phenotypes and macrophage competition for arginine metabolism affect the severity of muscle pathology in muscular dystrophy. Hum Mol Genet. 2009;18:482\u201396. https:\/\/doi.org\/10.1093\/hmg\/ddn376.","journal-title":"Hum Mol Genet"},{"key":"1805_CR40","doi-asserted-by":"publisher","first-page":"4869","DOI":"10.1007\/s00018-019-03255-6","volume":"76","author":"L Fantuzzi","year":"2019","unstructured":"Fantuzzi L, Tagliamonte M, Gauzzi MC, Lopalco L. Dual CCR5\/CCR2 targeting: opportunities for the cure of complex disorders. Cell Mol Life Sci. 2019;76:4869\u201386. https:\/\/doi.org\/10.1007\/s00018-019-03255-6.","journal-title":"Cell Mol Life Sci"},{"key":"1805_CR41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1096\/fj.201600619R","volume":"31","author":"W Zhao","year":"2017","unstructured":"Zhao W, Wang X, Ransohoff RM, Zhou L. CCR2 deficiency does not provide sustained improvement of muscular dystrophy in mdx5cv mice. FASEB J. 2017;31:35\u201346. https:\/\/doi.org\/10.1096\/fj.201600619R.","journal-title":"FASEB J"},{"key":"1805_CR42","doi-asserted-by":"publisher","unstructured":"Rizzo G, Di Maggio R, Benedetti A, Morroni J, Bouche M, Lozanoska-Ochser B. Splenic Ly6Chi monocytes are critical players in dystrophic muscle injury and repair. JCI Insight. 2020;30. https:\/\/doi.org\/10.1172\/jci.insight.130807.","DOI":"10.1172\/jci.insight.130807"},{"key":"1805_CR43","doi-asserted-by":"publisher","first-page":"11624","DOI":"10.1038\/ncomms11624","volume":"7","author":"EH Kobayashi","year":"2016","unstructured":"Kobayashi EH, Suzuki T, Funayama R, Nagashima T, Hayashi M, Sekine H, et al. Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription. Nat Commun. 2016;7:11624. https:\/\/doi.org\/10.1038\/ncomms11624.","journal-title":"Nat Commun"},{"key":"1805_CR44","doi-asserted-by":"publisher","first-page":"e0194421","DOI":"10.1371\/journal.pone.0194421","volume":"13","author":"F Liang","year":"2018","unstructured":"Liang F, Giordano C, Shang D, Li Q, Petrof BJ. The dual CCR2\/CCR5 chemokine receptor antagonist Cenicriviroc reduces macrophage infiltration and disease severity in Duchenne muscular dystrophy (Dmdmdx-4Cv) mice. PLoS One. 2018;13:e0194421. https:\/\/doi.org\/10.1371\/journal.pone.0194421.","journal-title":"PLoS One"},{"issue":"5","key":"1805_CR45","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1093\/hmg\/ddn408","volume":"18","author":"Y Iwata","year":"2009","unstructured":"Iwata Y, Katanosaka Y, Arai Y, Shigekawa M, Wakabayashi S. Dominant-negative inhibition of Ca2+ influx via TRPV2 ameliorates muscular dystrophy in animal models. Hum Mol Genet. 2009;18(5):824\u201334. https:\/\/doi.org\/10.1093\/hmg\/ddn408.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"1805_CR46","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nm1736","volume":"14","author":"DP Millay","year":"2008","unstructured":"Millay DP, Sargent MA, Osinska H, Baines CP, Barton ER, Vuagniaux G, et al. Genetic and pharmacologic inhibition of mitochondrial-dependent necrosis attenuates muscular dystrophy. Nat Med. 2008;14(4):442\u20137. https:\/\/doi.org\/10.1038\/nm1736.","journal-title":"Nat Med"},{"issue":"1","key":"1805_CR47","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1038\/s41467-017-01146-7","volume":"8","author":"A Voit","year":"2017","unstructured":"Voit A, Patel V, Pachon R, Shah V, Bakhutma M, Kohlbrenner E, et al. Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice. Nat Commun. 2017;8(1):1068. https:\/\/doi.org\/10.1038\/s41467-017-01146-7.","journal-title":"Nat Commun"},{"issue":"7394","key":"1805_CR48","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nature10980","volume":"484","author":"SM Gehrig","year":"2012","unstructured":"Gehrig SM, van der Poel C, Sayer TA, Schertzer JD, Henstridge DC, Church JE, et al. Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. Nature. 2012;484(7394):394\u20138. https:\/\/doi.org\/10.1038\/nature10980.","journal-title":"Nature."},{"key":"1805_CR49","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.redox.2014.12.004","volume":"4","author":"S Garoby-Salom","year":"2015","unstructured":"Garoby-Salom S, Rouahi M, Mucher E, Auge N, Salvayre R, Negre-Salvayre A. Hyaluronan synthase-2 upregulation protects Smpd3-deficient fibroblasts against cell death induced by nutrient deprivation, but not against apoptosis evoked by oxidized LDL. Redox Biol. 2015;4:118\u201326. https:\/\/doi.org\/10.1016\/j.redox.2014.12.004.","journal-title":"Redox Biol"},{"issue":"17","key":"1805_CR50","doi-asserted-by":"publisher","first-page":"13620","DOI":"10.1074\/jbc.M111.304857","volume":"287","author":"J Qin","year":"2012","unstructured":"Qin J, Berdyshev E, Poirer C, Schwartz NB, Dawson G. Neutral sphingomyelinase 2 deficiency increases hyaluronan synthesis by up-regulation of Hyaluronan synthase 2 through decreased ceramide production and activation of Akt. J Biol Chem. 2012;287(17):13620\u201332. https:\/\/doi.org\/10.1074\/jbc.M111.304857.","journal-title":"J Biol Chem"},{"key":"1805_CR51","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jneuroim.2004.10.026","volume":"160","author":"O Schulte-Herbr\u00fcggen","year":"2005","unstructured":"Schulte-Herbr\u00fcggen O, Nassenstein C, Lommatzsch M, Quarcoo D, Renz H, Braun A. Tumor necrosis factor-alpha and interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes. J Neuroimmunol. 2005;160:204\u20139. https:\/\/doi.org\/10.1016\/j.jneuroim.2004.10.026.","journal-title":"J Neuroimmunol"},{"key":"1805_CR52","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1002\/path.4228","volume":"231","author":"E Colombo","year":"2013","unstructured":"Colombo E, Bedogni F, Lorenzetti I, Landsberger N, Previtali SC, Farina C. Autocrine and immune cell-derived BDNF in human skeletal muscle: implications for myogenesis and tissue regeneration. J Pathol. 2013;231:190\u20138. https:\/\/doi.org\/10.1002\/path.4228.","journal-title":"J Pathol"},{"key":"1805_CR53","doi-asserted-by":"publisher","first-page":"5739","DOI":"10.1523\/JNEUROSCI.5398-05.2006","volume":"26","author":"K Mousavi","year":"2006","unstructured":"Mousavi K, Jasmin BJ. BDNF is expressed in skeletal muscle satellite cells and inhibits myogenic differentiation. J Neurosci. 2006;26:5739\u201349. https:\/\/doi.org\/10.1523\/JNEUROSCI.5398-05.2006.","journal-title":"J Neurosci"},{"key":"1805_CR54","doi-asserted-by":"publisher","first-page":"7713","DOI":"10.1038\/ncomms8713","volume":"6","author":"R Wu","year":"2015","unstructured":"Wu R, Li H, Zhai L, Zou X, Meng J, Zhong R, et al. MicroRNA-431 accelerates muscle regeneration and ameliorates muscular dystrophy by targeting Pax7 in mice. Nat Commun. 2015;6:7713. https:\/\/doi.org\/10.1038\/ncomms8713.","journal-title":"Nat Commun"},{"key":"1805_CR55","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1093\/hmg\/ddv055","volume":"24","author":"X Mu","year":"2015","unstructured":"Mu X, Tang Y, Lu A, Takayama K, Usas A, Wang B, et al. The role of Notch signaling in muscle progenitor cell depletion and the rapid onset of histopathology in muscular dystrophy. Hum Mol Genet. 2015;24:2923\u201337. https:\/\/doi.org\/10.1093\/hmg\/ddv055.","journal-title":"Hum Mol Genet"},{"key":"1805_CR56","doi-asserted-by":"publisher","first-page":"e0188821","DOI":"10.1371\/journal.pone.0188821","volume":"12","author":"Y Nagata","year":"2017","unstructured":"Nagata Y, Kiyono T, Okamura K, Goto YI, Matsuo M, Ikemoto-Uezumi M, et al. Interleukin-1beta (IL-1\u03b2)-induced Notch ligand Jagged1 suppresses mitogenic action of IL-1\u03b2 on human dystrophic myogenic cells. PLoS One. 2017;12:e0188821. https:\/\/doi.org\/10.1371\/journal.pone.0188821.","journal-title":"PLoS One"},{"key":"1805_CR57","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.nbd.2015.11.018","volume":"86","author":"M Fuenzalida","year":"2016","unstructured":"Fuenzalida M, Espinoza C, Perez MA, Tapia-Rojas C, Cuitino L, Brandan E, et al. Wnt signaling pathway improves central inhibitory synaptic transmission in a mouse model of Duchenne muscular dystrophy. Neurobiol Dis. 2016;86:109\u201320. https:\/\/doi.org\/10.1016\/j.nbd.2015.11.018.","journal-title":"Neurobiol Dis"},{"key":"1805_CR58","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1111\/j.1471-4159.2011.07192.x","volume":"118","author":"N Kuczewski","year":"2011","unstructured":"Kuczewski N, Fuchs C, Ferrand N, Jovanovic JN, Gaiarsa JL, Porcher C. Mechanism of GABAB receptor-induced BDNF secretion and promotion of GABAA receptor membrane expression. J Neurochem. 2011;118:533\u201345. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07192.x.","journal-title":"J Neurochem"},{"key":"1805_CR59","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/j.1471-4159.2007.04635.x","volume":"102","author":"X Li","year":"2007","unstructured":"Li X, Serwanski DR, Miralles CP, Bahr BA, De Blas AL. Two pools of Triton X-100-insoluble GABAA receptors are present in the brain, one associated to lipid rafts and another one to the post-synaptic GABAergic complex. J Neurochem. 2007;102:1329\u201345. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.04635.x.","journal-title":"J Neurochem"},{"key":"1805_CR60","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1017\/S146114571200140X","volume":"16","author":"C Nothdurfter","year":"2013","unstructured":"Nothdurfter C, Tanasic S, Di Benedetto B, Uhr M, Wagner EM, Gilling KE, et al. Lipid raft integrity affects GABAA receptor, but not NMDA receptor modulation by psychopharmacological compounds. Int J Neuropsychopharmacol. 2013;16:1361\u201371. https:\/\/doi.org\/10.1017\/S146114571200140X.","journal-title":"Int J Neuropsychopharmacol"},{"key":"1805_CR61","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1083\/jcb.200404106","volume":"167","author":"S Suzuki","year":"2004","unstructured":"Suzuki S, Numakawa T, Shimazu K, Koshimizu H, Hara T, Hatanaka H, et al. BDNF-induced recruitment of TrkB receptor into neuronal lipid rafts: roles in synaptic modulation. J Cell Biol. 2004;167:1205\u201315. https:\/\/doi.org\/10.1083\/jcb.200404106.","journal-title":"J Cell Biol"},{"key":"1805_CR62","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.bbamem.2010.06.028","volume":"2011","author":"AM Sebastiao","year":"1808","unstructured":"Sebastiao AM, Assaife-Lopes N, Diogenes MJ, Vaz SH, Ribeiro JA. Modulation of brain-derived neurotrophic factor (BDNF) actions in the nervous system by adenosine A2A receptors and the role of lipid rafts. Biochim Biophys Acta. 1808;2011:1340\u20139. https:\/\/doi.org\/10.1016\/j.bbamem.2010.06.028.","journal-title":"Biochim Biophys Acta"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01805-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12916-020-01805-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-020-01805-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,19]],"date-time":"2020-11-19T02:03:07Z","timestamp":1605751387000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedicine.biomedcentral.com\/articles\/10.1186\/s12916-020-01805-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,19]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1805"],"URL":"https:\/\/doi.org\/10.1186\/s12916-020-01805-5","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,19]]},"assertion":[{"value":"28 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the guidelines set out in the Declaration of Helsinki and was approved by the Research Ethics Committee of the NCNP (approval ID: A2011-113). Informed consent was obtained from all participants before they were enrolled in the trial. All mice lines used in this study were treated in accordance with the guidelines provided by the Ethics Committee for the Treatment of Laboratory Animals of the National Center of Neurology and Psychiatry (approval ID: 2015006), which has adopted the three fundamental principles of replacement, reduction, and refinement.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"343"}}